Status: Recruiting
Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System
Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.
Participants needed: 30
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Nyra Medical, Inc.Updated: Jul 28, 2026Locations: 3
Eligibility criteria
Age > 21 years at time of enrollment [+4]
Estimated life expectancy of less than 12 months [+15]